EraGen Antes Up in Anthrax-Detection Market With Own DNA-Based Product

Nov 07, 2001

NEW YORK, Nov. 7 - EraGen Biosciences on Wednesday threw its hat into the anthrax-detecting ring by announcing that it has developed a test that can detect the bacterium more rapidly than currently available tests.

The test, which is based on the company’s AEGIS technology, may help physicians reduce the time to detect the Bacillus anthracis “from days to hours,” EraGen said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Not Mentioning It

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

Lost Some Value There

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Slight Budget Trim

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

This Week in PLOS

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.

Main menu